Selexipag
Pharm Company: * MSN LABORATORIES PRIVATE LTDCategory: Blood Pressure
Selexipag, sold under the brand name Uptravi, is a medication developed by Actelion for the treatment of pulmonary arterial hypertension (PAH).[1] Selexipag and its active metabolite, ACT-333679 (or MRE-269, the free carboxylic acid), are agonists of the prostacyclin receptor, which leads to vasodilation in the pulmonary circulation.[2] It is taken by mouth or administered intravenously.[1][3] Contents 1 Contraindications 2 Adv... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
Selexipag 200 ug/1 Oral Tablet, Film Coated
NDC: 70710-1551
Labeler:
Zydus Pharmaceuticals (Usa) Inc.
Selexipag 400 ug/1 Oral Tablet, Film Coated
NDC: 70710-1552
Labeler:
Zydus Pharmaceuticals (Usa) Inc.
Selexipag 600 ug/1 Oral Tablet, Film Coated
NDC: 70710-1553
Labeler:
Zydus Pharmaceuticals (Usa) Inc.
Selexipag 800 ug/1 Oral Tablet, Film Coated
NDC: 70710-1554
Labeler:
Zydus Pharmaceuticals (Usa) Inc.
Selexipag 1000 ug/1 Oral Tablet, Film Coated
NDC: 70710-1555
Labeler:
Zydus Pharmaceuticals (Usa) Inc.
Selexipag 1200 ug/1 Oral Tablet, Film Coated
NDC: 70710-1556
Labeler:
Zydus Pharmaceuticals (Usa) Inc.
Selexipag 1400 ug/1 Oral Tablet, Film Coated
NDC: 70710-1557
Labeler:
Zydus Pharmaceuticals (Usa) Inc.
Selexipag 1600 ug/1 Oral Tablet, Film Coated
NDC: 70710-1558
Labeler:
Zydus Pharmaceuticals (Usa) Inc.
Related Brands
Drugs with the same active ingredients